Canada: Food and Drugs Law

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Life Sciences-Health Canada Takes Action Against Unauthorized Peptide Sales
On July 29, 2026, Health Canada announced that it had obtained a permanent injunction against a Québec-based company in connection with the sale of unauthorized injectable peptides in Canada. The announcement reflects Health Canada’s continued focus on peptide products and serves as a reminder that injectable peptides intended for human use are regulated as prescription drugs and are subject to Canada's drug regulatory framework.
Canada Healthcare
F
Fasken
Article
Health Canada Launches New Public Search Portal And Updated Guidance For Clinical Trials
Health Canada has launched a new public search portal for clinical trials authorized in Canada, alongside updated guidance documents for sponsors and applicants. The portal enhances transparency by making information about authorized clinical trials more readily accessible to patients, researchers, and industry stakeholders, while the updated guidance clarifies expectations for trial registration, summary results reporting, and public disclosure.
Canada Healthcare
TL
Torys LLP
Article
Teva And Samsung Bioepis Enter Into Commercialization Agreement For OPUVIZ In Canada
Teva Pharmaceutical Industries and Samsung Bioepis have announced a strategic partnership to commercialize OPUVIZ, a biosimilar referencing EYLEA, in the Canadian market. The agreement divides responsibilities between Samsung Bioepis handling product registration and manufacturing while Teva Canada leads commercialization efforts. OPUVIZ has already received Health Canada approval for treating multiple eye conditions including wet age-related macular degeneration and diabetic macular edema.
Canada Healthcare
GP
Goodwin Procter LLP
Article
The More Things Change, The More They Stay The Same: The Supreme Court Determines The Patentability Of Methods Of Medical Treatment
The Supreme Court of Canada has issued its most significant ruling on medical treatment patents in over fifty years, addressing whether dosing-regimen claims for schizophrenia medication constitute unpatentable methods of medical treatment. The 7-2 decision establishes a new framework for evaluating pharmaceutical patents, focusing on whether implementing the claimed invention requires professional medical skill and judgment. This landmark case provides crucial guidance for life sciences companies seeking p
Canada IP
C
Cassels
Article
Supreme Court Of Canada Declines To Overturn Prohibition On Patenting Methods Of Medical Treatment
The Supreme Court of Canada has issued a landmark ruling on whether methods of medical treatment can be patented in Canada, addressing a long-standing prohibition that has shaped the country's intellectual property landscape. The decision examines the boundaries between patentable medical innovations and unpatentable professional medical judgment, with particular focus on dosing regimens and treatment protocols. This ruling provides critical guidance for pharmaceutical companies, patent practitioners, and h
Canada IP
OW
Oyen Wiggs Green & Mutala LLP
Article
Les faits saillants du premier semestre de 2026 au Canada en matière de PI en sciences de la vie et de droit réglementaire
L'équipe responsable des mises à jour PI Rx examine les développements majeurs en propriété intellectuelle et en droit réglementaire des sciences de la vie au Canada durant le premier semestre 2026, incluant les nouvelles lignes directrices de la Cour fédérale, les initiatives de Santé Canada et les mises à jour du CEPMB et de l'AMC.
Canada Healthcare
SB
Smart & Biggar
Article
La Cour Fédérale Clarifie La Procédure Applicable Aux Requêtes En Jugement Sommaire Et En Procès Sommaire
Le 22 juin 2026, la Cour fédérale a publié des lignes directrices modifiées établissant de nouvelles procédures pour les requêtes en jugement sommaire et en procès sommaire dans les affaires de propriété intellectuelle. Ces directives précisent les délais de présentation, les questions appropriées pour chaque type de procédure, et introduisent un mécanisme de résolution des litiges concernant l'admissibilité des proc&#
Canada Litigation
SB
Smart & Biggar
Article
Legislative Update Report No. 2026-12 Le Bulletin D’actualités Législatives
This comprehensive legislative update compiles recent bills, regulations, proclamations, and notices from federal, provincial, and territorial jurisdictions across Canada. How do these diverse legislative changes across multiple jurisdictions impact regulatory compliance and legal practice in areas ranging from environmental protection to securities regulation?
Canada Government
OH
Osler, Hoskin & Harcourt LLP
Article
Projet De Loi 9 : Québec Interdit La Vente De Boissons Énergisantes Aux Mineurs De Moins De 16 Ans
Le 10 juin 2026, Québec a adopté le Projet de loi 9, Loi visant à prévenir les effets nocifs des boissons énergisantes sur la santé des jeunes (« Loi 9 »), qui introduit un changement important dans la façon dont les boissons énergisantes contenant de la caféine seront commercialisées dans la province. La Loi 9 entrera en vigueur six mois après la sanction, qui devrait être imminente.
Canada Healthcare
FF
Fasken (French)
See more

Latest Videos

See more